| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neumora Therapeutics, Inc. (NMRA) has 12 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. NMRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 6.05M | $11.07M | - | |
| 10% | 6.05M | $11.07M | - | |
| 10% | 6.05M | $11.07M | - | |
| Other | 1.65M | $3.02M | - | |
| Pres | 1.20M | $2.20M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2023 | Gosebruch Henry O53 | President &CEO | Buy | 15,000 | $12.62 | $189,370.50 | New | +22.6% | +1.9% |